PATENT CLAIM ANALYSIS

Application Number: 16034123
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["424", "172100"]

Abstract:
Disclosed herein are methods for treating cancer comprising administering CAR-modified immune cells and at least one Retinoic Acid Receptor and/or Retinoid X Receptor active agent.

Claim (Index 4):
The method of  claim 1 , wherein the CAR-MIC are cultured in a culture medium comprising an immunomodulatory RAR/RXR active agent prior to being administered to the subject.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 95.0
- Lexical Diversity: 1.04
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16034064', '15868469', '15620411', '15868459', '15868450']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7621055677933649
- 35 USC 102 Novelty (BERT): 0.6155457889254737
- Combined Prediction Score: 0.7474495899065757
- Mean Citation Score: 429.469826
- Max Citation Score: 564.1613
- Similarity Product: 518.1319529827833

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test